RT Journal Article
SR Electronic
A1 Vinall, Maria
T1 PR—Fampridine Improves Mobility in Patients with MS
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 29
SP 17
OP 17
DO 10.1177/155989771429014
UL http://mdc.sagepub.com/content/14/29/17.1.abstract
AB Prolonged release (PR)-fampridine treatment resulted in sustained and clinically meaningful improvement in walking ability and balance throughout a 6-month treatment period in individuals with multiple sclerosis (MS). The Exploratory Study to Assess the Effect of Fampridine (BIIB041) on Walking Ability and Balance in Participants With Multiple Sclerosis study [MOBILE; NCT01597297; Hupperts R et al. ACTRIMS/ECTRIMS 2014 (poster P922)] evaluated the effect of PR-fampridine on walking ability, dynamic and static balance, and subjective impressions of well-being.